National Cancer Center, Korea

This study tests whether a combination of surgery and heated chemotherapy (HIPEC) can help people with ovarian cancer that no longer responds to standard platinum-based chemo. About 140 adults with resectable tumors in the abdomen will be randomly assigned to get either surgery a…

This study tests whether adding atezolizumab (an immunotherapy) to capecitabine (a chemotherapy pill) works better than capecitabine alone in preventing breast cancer from returning. It involves 284 adults with triple-negative breast cancer who still had cancer after initial chem…

This study tests a drug called lurbinectedin in people with high-grade pancreatic neuroendocrine tumors (a rare, fast-growing cancer) who have already tried standard treatments. The goal is to see if the drug can shrink or control the tumor. About 46 adults will take part in this…

This study tests a combination of two drugs, pembrolizumab and lenvatinib, in 30 adults with advanced adrenal cancer that has not responded to standard chemotherapy. The goal is to see if this treatment can shrink tumors or slow the disease. Participants receive the drugs intrave…

This study aims to create a large registry of nearly 7,000 pancreatic cancer patients by combining past records (2010-2022) and new data from over 800 patients (2023-2029). Researchers will use this real-world information to generate clinical evidence and explore how biomarkers r…